These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 3258244)

  • 21. Effect of the D1 receptor agonist SKF 38393 on some behavioural effects of apomorphine in rats.
    Zarkovsky AM; Cereska KS
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Apr; 339(4):383-6. PubMed ID: 2567965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. D1 and D2 dopamine receptor mechanisms in dopaminergic behaviors.
    Koller WC; Herbster G
    Clin Neuropharmacol; 1988 Jun; 11(3):221-31. PubMed ID: 3261198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SCH-23390 antagonism of a D-2 dopamine agonist depends upon catecholaminergic neurons.
    Breese GR; Mueller RA
    Eur J Pharmacol; 1985 Jul; 113(1):109-14. PubMed ID: 2864260
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.
    Arnt J
    Eur J Pharmacol; 1985 Jul; 113(1):79-88. PubMed ID: 2931283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic interaction between dopamine D-1 and D-2 receptor agonists: circling behaviour of rats with hemitransection.
    Arnt J; Perregaard J
    Eur J Pharmacol; 1987 Nov; 143(1):45-53. PubMed ID: 3500865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory role of D-1 dopamine receptors for the jerks induced by B-HT 920 in rats.
    Grabowska-Andén M; Andén NE
    J Pharm Pharmacol; 1987 Aug; 39(8):660-1. PubMed ID: 2888862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Responses to selective D-1 and D-2 agonists after repeated treatment with selective D-1 and D-2 antagonists.
    Gandolfi O; Dall'olio R; Vaccheri A; Roncada P; Montanaro N
    Pharmacol Biochem Behav; 1988 Jun; 30(2):463-9. PubMed ID: 3262877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of D-1 and D-2 receptors in apomorphine-induced pecking in chicks.
    Zarrindast MR; Amin R
    Psychopharmacology (Berl); 1992; 106(1):67-70. PubMed ID: 1346722
    [TBL] [Abstract][Full Text] [Related]  

  • 29. D-1 dopamine receptor stimulation enables the inhibition of nucleus accumbens neurons by a D-2 receptor agonist.
    White FJ
    Eur J Pharmacol; 1987 Mar; 135(1):101-5. PubMed ID: 3494620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. D-1 dopamine receptors and arousal.
    Ongini E
    Adv Exp Med Biol; 1988; 235():169-78. PubMed ID: 2976250
    [No Abstract]   [Full Text] [Related]  

  • 31. Behavioural expression of D-1 receptor supersensitivity depends on previous stimulation of D-2 receptors.
    Morelli M; Fenu S; Di Chiara G
    Life Sci; 1987 Jan; 40(3):245-51. PubMed ID: 2948094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats.
    Imperato A; Tanda G; Frau R; Di Chiara G
    J Pharmacol Exp Ther; 1988 Apr; 245(1):257-64. PubMed ID: 3258912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats.
    Arnt J; Hyttel J; Perregaard J
    Eur J Pharmacol; 1987 Jan; 133(2):137-45. PubMed ID: 2949991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interaction of D1 and D2 dopamine receptors in the expression of dopamine agonist induced behaviors.
    Braun AR; Barone P; Chase TN
    Adv Exp Med Biol; 1986; 204():151-66. PubMed ID: 2947426
    [No Abstract]   [Full Text] [Related]  

  • 35. Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum.
    Stoof JC; Kebabian JW
    Nature; 1981 Nov; 294(5839):366-8. PubMed ID: 6273735
    [No Abstract]   [Full Text] [Related]  

  • 36. Repeated stimulation of dopamine D1 receptors enhances the effects of dopamine receptor agonists.
    White FJ; Hu XT; Brooderson RJ
    Eur J Pharmacol; 1990 Dec; 191(3):497-9. PubMed ID: 1982272
    [No Abstract]   [Full Text] [Related]  

  • 37. Sniffing, rearing and locomotor responses to the D-1 dopamine agonist R-SK&F 38393 and to apomorphine: differential interactions with the selective D-1 and D-2 antagonists SCH 23390 and metoclopramide.
    Molloy AG; Waddington JL
    Eur J Pharmacol; 1985 Feb; 108(3):305-8. PubMed ID: 3886407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thienopyridine derivatives identified as the first selective, full efficacy, dopamine D1 receptor agonists.
    Andersen PH; Nielsen EB; Scheel-Krüger J; Jansen JA; Hohlweg R
    Eur J Pharmacol; 1987 Jun; 137(2-3):291-2. PubMed ID: 2956116
    [No Abstract]   [Full Text] [Related]  

  • 39. Evidence for post-synaptic changes mediating increased behavioural sensitivity to dopamine receptor agonists in hypothyroid rats.
    Crocker AD; Cameron DL
    Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(5):607-15. PubMed ID: 3065827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential inhibition by dopamine D-1 and D-2 antagonists of circling behaviour induced by dopamine agonists in rats with unilateral 6-hydroxydopamine lesions.
    Arnt J; Hyttel J
    Eur J Pharmacol; 1984 Jul; 102(2):349-54. PubMed ID: 6148252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.